Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1642-1645

  Petraitis, Vidmantas ^a,d   Petraitiene, Ruta ^a,d   Lin, Pengxin ^a   Calis, Karim ^c   Kelaher, Amy M ^a   Muray, Heidi A ^a   Mya San, Christine ^a   Mickiene, Diana ^a   Bacher, John ^b   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Office of Research Services   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; GENERIC DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; LUNG ASPERGILLOSIS; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; DRUGS, GENERIC; LUNG DISEASES, FUNGAL; NEUTROPENIA; RABBITS;

EID: 20144389443     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1642-1645.2005     Document Type: Article

References (17)

1. Alexander, M. R. 1974. Review of vancomycin after 15 years of use. Drug Intell. Clin. Pharm. 8:520.
2. Anaissie, E. 1992. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis. 14(Suppl. 1):S43-S53.
3. Cleary, J. D., P. D. Rogers, and S. W. Chapman. 2003. Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations. Pharmacotherapy 23:572-578.
4. Denning, D. W. 2001. Chronic forms of pulmonary aspergillosis. Clin. Microbiol. Infect. 7(Suppl. 2):25-31.
5. Eng, R. H., L. Wynn, S. M. Smith, and F. Tecson-Tumang. 1989. Effect of intravenous vancomycin on renal function. Chemotherapy 35:320-325.
6. Espinel-Ingroff, A., M. Bartlett, R. Bowden, N. X. Chin, C. Cooper, Jr., A. Fothergill, M. R. McGinnis, P. Menezes, S. A. Messer, P. W. Nelson, F. C. Odds, L. Pasarell, J. Peter, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, G. S. Shankland, T. J. Walsh, and I. Weitzman. 1997. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143.
7. Francis, P., J. W. Lee, A. Hoffman, J. Peter, A. Francesconi, J. Bacher, J. Shelhamer, P. A. Pizzo, and T. J. Walsh. 1994. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J. Infect. Dis. 169:356-368.
8. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed., p. 55-459. Marcel Dekker, Inc., New York, N.Y.
9. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23-32.
10. Groll, A. H., N. Giri, V. Petraitis, R. Petraitiene, M. Candelario, J. S. Bacher, S. C. Piscitelli, and T. J. Walsh. 2000. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J. Infect. Dis. 182:274-282.
11. Ingerman, M. J., and J. Santoro. 1989. Vancomycin. A new old agent. Infect. Dis. Clin. N. Am. 3:641-651.
12. Latge, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
13. National Committee for Clinical Laboratory Standards. 2000. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. National Research Council Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission on Life Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
15. Pannuti, C., R. Gingrich, M. A. Pfaller, C. Kao, and R. P. Wenzel. 1992. Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer 69:2653-2662.
16. Wald, A., W. Leisenring, J. A. van Burik, and R. A. Bowden. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175:1459-1466.
17. Walsh, T. J., J. Bacher, and P. A. Pizzo. 1988. Chronic silastic central venous catheterization for induction, maintenance, and support of persistent granulocytopenia in rabbits. Lab. Anim. Med. 38:467-470.